Palatin Technologies (PTN) Gross Profit (2019 - 2024)
Palatin Technologies' (PTN) quarterly Gross Profit came in at $350000.0 in Q2 2024, down 78.85% YoY from $1.7 million in Q3 2023, and down 81.93% on a QoQ basis from $1.9 million in Q4 2023.
Palatin Technologies (PTN) Gross Profit (2019 - 2024) Analysis & Trends
Palatin Technologies (PTN) has 6 years of Gross Profit data on file, last reported at $350000.0 in Q2 2024.
- Quarterly Gross Profit fell 78.85% year-over-year to $350000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2025 was $350000.0 (down 92.03% YoY) and the FY2024 annual result came in at $4.4 million, down 0.9% from the prior year.
- Gross Profit declined to $350000.0 in Q2 2024, from $1.9 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $2.1 million in Q3 2023 to a low of -$212993.0 in Q2 2021.
- A 5-year average of $669588.5 and a median of $350000.0 in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit jumped 641.99% — and 2024, when it sank 78.85%.
- Tracing PTN's Gross Profit over 5 years: stood at $134571.0 in 2020, then jumped by 117.71% to $292969.0 in 2021, then soared by 216.66% to $927709.0 in 2022, then soared by 108.74% to $1.9 million in 2023, then plunged by 81.93% to $350000.0 in 2024.
- The last three Gross Profit figures came in at $350000.0 (Q2 2024), $1.9 million (Q4 2023), and $2.1 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Sep 30, 2023 | 2.11 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 927,709.00 |
| Dec 31, 2022 | 927,709.00 |
| Sep 30, 2022 | 783,158.00 |
| Sep 30, 2022 | 783,158.00 |
| Jun 30, 2022 | 433,221.00 |
| Jun 30, 2022 | 433,221.00 |
| Mar 31, 2022 | 169,189.00 |
| Mar 31, 2022 | 169,189.00 |
| Dec 31, 2021 | 292,969.00 |
| Dec 31, 2021 | 292,969.00 |